Shares of Haleon plc (NYSE:HLN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the ...

The feature-length film from Sensodyne profiled several subjects in the neurodivergent and sensory sensitivity space, ...

Haleon-owned over-the-counter pain medication Panadol is making an effort to be more inclusive in its messaging.

Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for European expansion.

Barclays analyst Iain Simpson maintained a Buy rating on Haleon PLC (HLN – Research Report) today and set a price target of £4.15. The ...

On Sunday, Haleon PLC – ADR (HLN) stock saw a decline, ending the day at $9.47 which represents a decrease of $-0.10 or -1.04% from the prior close of $9.57. The stock opened at $9.37 and touched a ...

PFG Investments LLC trimmed its position in Haleon plc (NYSE:HLN – Free Report) by 11.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

X-ELIO, a global leader in renewable energy, has signed a multi-buyer Power Purchase Agreement (PPA) with an Energize program ...

Activist investment firm Starboard Value has launched a proxy battle with pharmacy supplier Kenvue, running a slate of four board nominees including Starboard head Jeff Smith.

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

In a recent regulatory filing, Haleon plc (LSE/NYSE: LON:HLN), a prominent player in the consumer health sector with a market capitalization of $41.7 billion, disclosed its updated total number of ...